Neuromuscular Disorders: In Vitro

This feed focuses on experimental systems, including cell and tissue-based therapies, as well as genomic and proteomic approaches, used to study neuromuscular disorders in vitro.

March 23, 2020

Increased Risk of Sudden Cardiac Death in Schizophrenia

Psychosomatics
Carla A ScorzaRoberta M Cysneiros
March 17, 2020
ReviewOpen Access

DNA Editing Enzymes as Potential Treatments for Heteroplasmic mtDNA Diseases

Journal of Internal Medicine
Ugne ZekonyteCarlos T Moraes
May 2, 2020
Open Access

Deciphering the protein dynamics of iPSC-derived neurons

Journal of Proteome Research
Suzy VarderidouMaarten Altelaar
May 14, 2020

Alcohol and sudden unexpected death in epilepsy: do not pop the cork

Clinics
Carla A ScorzaFulvio A Scorza
April 23, 2020
ReviewOpen Access

Update Review about Metabolic Myopathies

Life
Josef Finsterer
April 16, 2020

Targeted Treatments for Inherited Neuromuscular Diseases of Childhood

Seminars in Neurology
Alex J FayJonathan Strober
May 1, 2020

MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Valentina PegoraroCorrado Angelini
March 12, 2020

Multisystem presentation of a homozygous POLG2 variant

European Journal of Medical Genetics
Josef Finsterer
March 18, 2020
Open Access

Functional restoration of ex vivo model of pylorus: Co-injection of neural progenitor cells and interstitial cells of Cajal

Stem Cells Translational Medicine
Prabhash Dadhich, Khalil N Bitar
April 7, 2020

Transient Heart Failure Followed by Claudication of the Lower Limbs Due to Takayasu Vasculitis With Concomitant Myositis

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
Claudia StöllbergerJosef Finsterer
March 3, 2020

New insights on stem cells modeling and treatment of human diseases

Frontiers in Bioscience (Landmark Edition)
Geeta RaiKushbu Priya
May 31, 2020

Domperidone in Parkinson's disease: a valuable controversy, but unnecessary panic

Family Practice
Daniella Balduino VictorinoFulvio A Scorza
April 8, 2020

Activity in grafted human iPS cell-derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior

Proceedings of the National Academy of Sciences of the United States of America
Sara Palma-TortosaZaal Kokaia
April 19, 2020

Inflammation and "The Epileptic Heart"

Epilepsy & Behavior : E&B
Mariana NejmFulvio A Scorza

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuromuscular-disorders-in-vitro/60d14e6a-e0fd-4e9c-8c49-3abfd322698c